British Society for Rheumatology 2026 guideline on polymyalgia rheumatica, replacing the 2009 guidance: covers referral, glucocorticoid start and faster taper options, early methotrexate, IL-6 receptor antagonists when tapering fails, and bone protection for all.
Guideline
Toyoda et al. The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica